Today again with$ARCC (-0,36%) topped up today. Now it's enough for the start, and from next month I'll turn my attention to the next position in order to diversify even more. I have especially $CL (+1,52%) or $SCI (-1,57%) in mind. What have you bought in the last few days?
Discussão sobre CL
Postos
31Quarterly figures 28.07-01.08
$HEIA (-0,43%)
$EL (-0,82%)
$NUE (+1,35%)
$CDNS (-0,85%)
$WM (-2,57%)
$MSFT (-3,17%)
$V (-2,85%)
$OR (-0,16%)
$AZN (-0,41%)
$MRK (+0%)
$PG (-0,18%)
$SBUX (-2,4%)
$BCS (-2,03%)
$META (-0,3%)
$BABA (+2,84%)
$QCOM (-0,6%)
$AIR (-1,53%)
$HSBC (+0,45%)
$GSK (+0,26%)
$MBG (-0,19%)
$F (-0,1%)
$AAPL (-0,66%)
$AMZN (-1,95%)
$MA (-2,53%)
$7203 (+0,48%)
$SHEL (-1,48%)
$005930
$SNY (+2,06%)
$CMCSA (-0,93%)
$COIN (-3,18%)
$NET (+1,08%)
$XOM (-3,47%)
$CVX (-3,05%)
$CS (-1,32%)
$NTDOY (-1,55%)
$CL (+1,52%)
$DTG (+0,3%)
$UNH (+1,39%)

Quarterly figures 21.07-25.07.25
Here is a clear overview of the quarterly figures due next week.
$NXPI (+0%)
$CLF (+7,76%)
$LOGN (+0,25%)
$KO (-1,09%)
$GM (-0,78%)
$LMT (+1,18%)
$NOC (-0,4%)
$PM (-0,51%)
$RYTT34
$UPS (+0,14%)
$V (-2,85%)
$T (-0,43%)
$FCX (+0,2%)
$GD (-1,21%)
$GOOGL (+0,59%)
$IBM (-0,15%)
$NOW (+1,08%)
$TSLA (+2,79%)
$DOW (+1,46%)
$HON (-0,54%)
$VLO (-0,39%)
$BMY (+0,02%)
$AON (-1,36%)
$CL (+1,52%)

Colgate-Palmolive Q1'25 Earnings Highlights:
🔹 Adj. EPS: $0.91 🟢 (Est. $0.86) | +6% YoY
🔹 Revenue: $4.91B 🟢 (Est. $4.89B) | -3.1% YoY
🔹 Organic Sales: +1.4% YoY
Guidance (FY25)
🔹 Organic Sales Growth: +2% to +4% (Est. +3.36%) 😐
🔹 EPS Growth: Low single digits
🔹 FX expected to be a low-single-digit headwind
Segment Performance
🔹 North America: Organic Sales -3.0%
🔹 Latin America: Organic Sales +4.0%
🔹 Europe: Organic Sales +5.4%
🔹 Hill’s Pet Nutrition: Organic Sales +2.9%
Operating Metrics
🔹 Gross Margin: +80 bps to 60.8%
🔹 Advertising Spend: +30 bps to 13.6% of sales
CEO Commentary
🔸 Focused on agility amid volatility; reaffirmed commitment to financial targets.
🔸 Tariff impacts included in outlook; FX remains a headwind.
Colgate is on - always.
$CL (+1,52%) The US company has been paying a profit share since 1895 and has been constantly increasing it for over 60 years. And this is exactly what Colgate has now announced again for this year: from the second quarter, there will be a four percent increase per share. I LOVE IT.
Portfolio Update
Dear community,
I have been investing for almost exactly 3 years now and pursue a dividend strategy with a "core" of 3 monthly saved ETFs.
After a personally difficult year in 2024, I am trying to keep my savings rate at € 200-300 per month in 2025.
This will be divided as follows:
50-100€ FTSE
30-50€ Europe
20-30€ EM IMI
The remaining approx. 100€ goes into my dividend share portfolio. I don't usually make any really strategic choices there to continue saving... I just save the ones I want... As I want to keep all the shares, I perhaps don't see any real reason to make a critical selection.
Maybe you can still give me some tips.
I would like to add 6 more dividend payers to my dividend portfolio in the future.
$CAT (+0,21%) , $CL (+1,52%) , $BATS (+0,05%) , $CSCO (-2,53%) , $SIE (-1,85%) , $WFC (-3,85%)
Thank you for your attention.
ColgatePalmolive (CL) Q4 2024 EarningsReport Summary
In Q4 2024, Colgate-Palmolive maintained its leadership in oral care but faced slight revenue declines. Despite a 0.1% drop in net sales, organic sales grew 4.3%, supported by price increases and strong performance in key markets. The company continued to invest in marketing (+15% YoY), digital transformation, and innovation to sustain long-term growth.
📊 Income Statement Highlights (Q4 2024 vs. Q4 2023)
▫️Net Income: $739M vs. $718M (+3%)
▫️Total Revenue: $4.94B vs. $4.95B (-0.1%)
▫️Adjusted EPS: $0.91 vs. $0.87 (+5%)
▫️Gross Margin: 60.3% vs. 59.6% (+70 bps)
▫️Operating Income: $1.06B vs. $1.07B (-1%)
▫️Non-GAAP Operating Margin: 21.7% (flat YoY)
▫️GAAP Operating Margin: 21.5% (-20 bps)
▫️Operating Cash Flow: $4.1B (+10% YoY)
▫️Advertising Expense: $648M (+15% YoY)
▫️Hill’s Pet Nutrition Revenue: $1.14B (+2.3%)
💼 Balance Sheet Highlights (Q4 2024 vs. Q4 2023)
▫️Total Assets: $16.05B vs. $15.82B
▫️Total Liabilities: $15.50B vs. $15.33B
▫️Cash & Equivalents: $1.10B (+13.5%)
▫️Debt: $7.95B
▫️Equity: $212M (↓ due to share buybacks)
▫️Free Cash Flow: $3.55B (+9.5%)
🔮 Future Outlook
2025 Guidance:
▫️Net sales expected to be flat due to FX headwinds (~5% impact).
▫️Organic sales growth of 3-5%, in line with long-term targets.
▫️Gross margin expansion driven by pricing and efficiency gains.
▫️Flat to slightly higher advertising spend to drive brand momentum.
▫️Mid-single-digit EPS growth, despite expected private label pet nutrition exit.
Colgate is well-positioned to sustain growth through brand investment, cost optimization, and global market leadership.
$CL (+1,52%) | Colgate-Palmolive Q3'24 Earnings Highlights
🔹 Revenue: $5.03B (Est. $5.01B) 🟢; UP +2.4% YoY
🔹 Base Business EPS: $0.91 (Est. $0.88) 🟢; UP +6% YoY
Narrowed FY24 Guidance:
🔹 Net Sales Growth: 3%-5% (Prev. 2%-5%)
🔹 Organic Sales Growth: 7%-8% (Prev. 6%-8%)
🔹 Non-GAAP EPS Growth: 10%-11% (Prev. 8%-11%)
Key Performance Metrics:
🔹 Organic Sales Growth: +6.8%
🔹 Gross Profit Margin (GAAP): 61.1% (vs. 58.5% YoY)
🔹 Base Business Gross Profit Margin: 61.3%; UP +270 bps YoY
Divisional Organic sales :
🔸 North America: -1.9%
🔸 Latin America: +14.2%
🔸 Europe: +6.3%
🔸 Asia Pacific: +6.1%
🔸 Hill's Pet Nutrition: +6.5%
Títulos em alta
Principais criadores desta semana